Bharat Biotech Covaxin Fact Sheet - Summary
Bharat Biotech Covaxin Fact Sheet
COVAXIN is India’s first indigenous COVID-19 vaccine, developed by Bharat Biotech in partnership with the Indian Council of Medical Research (ICMR) – National Institute of Virology (NIV). This vital vaccine plays a key role in India’s ongoing battle against COVID-19.
About COVAXIN
This homegrown and inactivated vaccine is manufactured in Bharat Biotech’s advanced BSL-3 (Bio-Safety Level 3) high containment facility. The implementation of strict safety protocols guarantees that the vaccine is safe for public use.
Technology Behind COVAXIN
COVAXIN utilizes Whole-Virion Inactivated Vero Cell derived platform technology. Being an inactivated vaccine, COVAXIN does not replicate, making it less likely to revert and cause any adverse effects. It comprises a dead virus that cannot infect people but effectively trains the immune system to combat future infections.
This makes COVAXIN a crucial asset in protecting against COVID-19. If you’re interested in more comprehensive information about this vaccine, don’t miss the chance to download our PDF for easy reference. You can find this important resource available for download below.